FDA Inspection 973109 — Changzhou Pharmaceutical Factory

Changzhou Pharmaceutical Factory — FEI 3002806661

The FDA completed an inspection of Changzhou Pharmaceutical Factory on May 20, 2016 in Changzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 20, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Changzhou (China)